MK-421 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - NEUROHUMORAL CORRELATES OF THE HEMODYNAMIC-RESPONSE TO ACUTE AND CHRONIC THERAPY

被引：0

作者：

DICARLO, L ^{[1
]}

CHATTERJEE, K ^{[1
]}

ATHERTON, B ^{[1
]}

CURRAN, D ^{[1
]}

PARMLEY, W ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143

来源：

CLINICAL RESEARCH | 1983年 / 31卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：A179 / A179

页数：1

共 50 条

[41] ENALAPRILAT, A NEW PARENTERAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RAPID CHANGES IN SYSTEMIC AND CORONARY HEMODYNAMICS AND HUMORAL PROFILE IN CHRONIC HEART-FAILURE
DEMARCO, T
DALY, PA
LIU, M
KAYSER, S
PARMLEY, WW
CHATTERJEE, K
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (05) : 1131 - 1138
[42] ACUTE EFFECTS OF CONVERTING ENZYME-INHIBITOR (CEI) IN CONGESTIVE HEART-FAILURE (CHF)
CEIMO, JM
FOUAD, FM
BRAVO, EL
TARAZI, RC
CIRCULATION, 1979, 60 (04) : 83 - 83
[43] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL IN TREATMENT OF PATIENTS WITH HYPERTENSION AND HEART-FAILURE
OLBINSKAYA, LI
MOROZOVA, TE
KARDIOLOGIYA, 1994, 34 (7-8) : A44 - A48
[44] HYPERTENSIVE CRISIS IN SYSTEMIC-SCLEROSIS - TREATMENT WITH THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 (ENALAPRIL) IN CAPTOPRIL-INTOLERANT PATIENTS
SMITH, CD
SMITH, RD
KORN, JH
ARTHRITIS AND RHEUMATISM, 1984, 27 (07): : 826 - 828
[45] TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE WITH CAPTOPRIL, AN ORAL INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME
DAVIS, R
RIBNER, HS
KEUNG, E
SONNENBLICK, EH
LEJEMTEL, TH
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03): : 117 - 121
[46] DIGOXIN AND ANGIOTENSIN CONVERTING ENZYME-INHIBITORS IN CHRONIC HEART-FAILURE
GHEORGHIADE, M
CANADIAN JOURNAL OF CARDIOLOGY, 1990, 6 : C14 - C17
[47] CORRELATION BETWEEN ANGIOTENSIN CONVERTING ENZYME-INHIBITION AND THE ACUTE HYPOTENSIVE RESPONSE TO MK-421 IN ESSENTIAL-HYPERTENSION
JACKSON, B
MCGRATH, BP
JOHNSTON, CI
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, : 99 - 104
[48] EVALUATION OF A LONG-ACTING CONVERTING ENZYME-INHIBITOR (ENALAPRIL) FOR THE TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE
CODY, RJ
COVIT, AB
SCHAER, GL
LARAGH, JH
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (04) : 1154 - 1159
[49] EFFECT OF ORALLY-ADMINISTERED HYDRALAZINE ON NEUROHUMORAL FACTORS AND HEMODYNAMIC-RESPONSE IN AGED PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE
UEDA, K
SAKAI, M
MATSUSHITA, S
KUWAJIMA, I
MURAKAMI, M
JAPANESE HEART JOURNAL, 1983, 24 (05): : 711 - 721
[50] HYDRALAZINE THERAPY IN SEVERE CHRONIC HEART-FAILURE - CAN RADIONUCLIDE ANGIOGRAPHY PREDICT THE HEMODYNAMIC-RESPONSE
GOLDBERG, MJ
FRANKLIN, BA
KERIN, NZ
WILLENS, HJ
RUBENFIRE, M
CLINICAL RESEARCH, 1981, 29 (04): : A692 - A692

← 1 2 3 4 5 →